An Economic Evaluation Of Single Tablet Regimens Of Antiretroviral Therapy For Treatment-Naitve Hiv-Infected Patients

The objective of this study is to perform a cost-utility analysis of STR using a decision model to assess the cost-effectiveness of tenofovir disoproxil fumarate/emtricitabine/rilpivirine (TDF/FTC/RPV) compared to tenofovir disoproxil fumarate/emtricitabine/efavirenz (TDF/FTC/EFV) for asymptomatic, treatment-na ïve HIV-infected patients.

Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: C Chou, F Terris-Prestholt, A Miners Source Type: research